BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Termination

BLADDER CANCER ADVOCACY NETWORK

via ATLAS ADVOCACY

2nd Quarter (Apr 1 - June 30) · 2022Posted Jul 29, 2022Filing document ↗LDA record ↗

Income$9Kfee reported

Client

Name: BLADDER CANCER ADVOCACY NETWORK
Description: Advocacy organization to advance bladder cancer research and support patients.
Location: Maryland · United States of America

Registrant

Firm: ATLAS ADVOCACY
Description: disinfectant manufacturing
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Congressionally Directed Medical Research Program Military burn pit legislation health care access
LobbyistsMATT SMITH · JON ROBINSON WADSWORTH · PATRICK F CAVANAGH
Covered position (MATT SMITH): Sen Dan Coates/ EOP/ Dept. of VA
Covered position (PATRICK F CAVANAGH): Legislative Director, Rep. Mike Doyle/ Legislative Assistant, Sen. Debbie Stabenow/ Legislative Assistant, Rep. Tim Holden
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

BLADDER CANCER ADVOCACY NETWORK — Lobbying — Receipts Report